Release Date: April 23, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you explain the impact of tariffs on your revenue and how it correlates with expected organic growth for the year? A: Robert Mehrabian, Executive Chairman, explained that the 1% reduction in revenue outlook includes the impact of tariffs and assumes a 1% hit to GDP. The impact is expected to be minimal on Aerospace and Defense or Engineered Systems but may affect Digital Imaging and Instruments slightly. The company is planning actions to mitigate these impacts, including pricing adjustments.
Q: How are you addressing potential margin pressures, especially in newly acquired businesses? A: Mehrabian noted that while acquisitions like Qioptiq initially lower margins, they are expected to improve over time. The company projects a 60 basis point margin improvement for the year, with Qioptiq expected to add $0.15 to overall earnings.
Q: Are you seeing more acquisition opportunities in the current economic environment? A: Mehrabian stated that while it's early, the company has a healthy acquisition pipeline. They have already spent $750 million on acquisitions this year and expect their debt-to-EBITDA ratio to decrease, providing more capacity for future acquisitions.
Q: What is the outlook for the Aerospace and Defense segment, considering the US FY26 budget and European rearmament? A: Mehrabian highlighted that US Defense sales increased by 18.7% year-over-year in Q1. The company expects to benefit from increased defense budgets in both the US and Europe, with a strong manufacturing footprint in Europe supporting growth.
Q: Have you started seeing any slowdown in Digital Imaging and Instrumentation due to tariffs, or are you just derisking due to uncertainty? A: Mehrabian mentioned that while there are some weaknesses in certain areas, the overall impact is more of a precautionary measure. The company's book-to-bill ratios remain positive, indicating resilience despite potential challenges.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.